Project Details
Description
A Multicenter, Prospective, Double-Blind, Randomized, Placebo-Controlled, Phase 3 Study of BB3 to Reduce the Severity of Delayed Graft Function in Recipients of a Deceased Donor Kidney
| Status | Finished |
|---|---|
| Effective start/end date | 4/1/18 → 6/30/22 |
Funding
- ANGION BIOMEDICA CORP
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.